Human papillomavirus vaccine [4]

New England Journal of Medicine

Volumn 357, Issue 11, 2007, Pages 1154-1156

  Miller, Nancy B ^a   Raychaudhuri, Gopa ^a   Toerner, Joseph G ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE; HUMAN PAPILLOMAVIRUS VACCINE L1, TYPE 6,11,16,18; PAPILLOMA VIRUS VACCINE; UNCLASSIFIED DRUG;

CANCER SCREENING; COLPOSCOPY; LETTER; PAPANICOLAOU TEST; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; WART VIRUS; ALPHAPAPILLOMAVIRUS; FEMALE; HUMAN; NOTE; UTERINE CERVIX TUMOR; VIRUS INFECTION;

ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS;

EID: 34548726085     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc071724     Document Type: Letter

References (5)

1. Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007;356:1928-43.
2. The FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007;356:1915-27.
3. Sawaya GF, Smith-McCune K. HPV vaccination - more answers, more questions. N Engl J Med 2007;356:1991-3.
4. Wright TC Jr, Cox JT, Massad LS, et al. 2001 Consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol 2003;189:295-304.
5. Gardasil [quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine]. Whitehouse Station, NJ: Merck, 2006 (package insert). (Accessed August 23, 2007, at http://www.fda.gov/cber/label/hpvmer040307LB.pdf.)